The fetal hypothalamic–pituitary–adrenal axis: Relevance to developmental origins of health and disease

Deborah M. Sloboda, John P. Newnham, Timothy J.M. Moss, John R.G. Challis

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

Introduction A clear relationship exists between intrauterine development and predisposition to postnatal disease. It is now understood that pre- and periconceptional nutritional status, glucocorticoid exposure and immediate postnatal development including catch-up growth may all contribute to these influences of early development on later-life disease. Barker and colleagues have described in detail the potential influence that an adverse intrauterine environment could play in the risk of developing particular diseases later in life (Barker 1994a, 1994b, 1995). It has been proposed that resetting of endocrine axes controlling growth and development could be one pathway for the developmental programming of later health and wellbeing. The fetal hypothalamic-pituitary-adrenal (HPA) axis in particular is highly vulnerable to changes in the intrauterine environment. Fetal HPA axis activity increases with gestation in most species and contributes to increased fetal levels of circulating glucocorticoids (Fowden et al. 1998). Even subtle changes in the intrauterine environment can disrupt the delicate balance of fetal HPA development and glucocorticoid production and can therefore alter long-term HPA activity and function. HPA hyperactivity has been demonstrated in animals after prenatal undernutrition (Lingas et al. 1999), prenatal stress (Takahashi and Kalin 1991) and maternal synthetic glucocorticoid administration (Uno et al. 1990, Sloboda et al. 2000). Programming of the fetal HPA axis during development appears to play a central role in the link between fetal growth and long-term disease in adulthood. Prenatal programming of HPA axis function may increase the risk of developing cardiovascular and metabolic diseases.

Original languageEnglish
Title of host publicationDevelopmental Origins of Health and Disease
PublisherCambridge University Press
Pages191-205
Number of pages15
ISBN (Electronic)9780511544699
ISBN (Print)0521847435, 9780521847438
DOIs
Publication statusPublished - 1 Jan 2006
Externally publishedYes

Cite this

Sloboda, D. M., Newnham, J. P., Moss, T. J. M., & Challis, J. R. G. (2006). The fetal hypothalamic–pituitary–adrenal axis: Relevance to developmental origins of health and disease. In Developmental Origins of Health and Disease (pp. 191-205). Cambridge University Press. https://doi.org/10.1017/CBO9780511544699.014
Sloboda, Deborah M. ; Newnham, John P. ; Moss, Timothy J.M. ; Challis, John R.G. / The fetal hypothalamic–pituitary–adrenal axis : Relevance to developmental origins of health and disease. Developmental Origins of Health and Disease. Cambridge University Press, 2006. pp. 191-205
@inbook{61ba730484c14ecd962f474d6791b251,
title = "The fetal hypothalamic–pituitary–adrenal axis: Relevance to developmental origins of health and disease",
abstract = "Introduction A clear relationship exists between intrauterine development and predisposition to postnatal disease. It is now understood that pre- and periconceptional nutritional status, glucocorticoid exposure and immediate postnatal development including catch-up growth may all contribute to these influences of early development on later-life disease. Barker and colleagues have described in detail the potential influence that an adverse intrauterine environment could play in the risk of developing particular diseases later in life (Barker 1994a, 1994b, 1995). It has been proposed that resetting of endocrine axes controlling growth and development could be one pathway for the developmental programming of later health and wellbeing. The fetal hypothalamic-pituitary-adrenal (HPA) axis in particular is highly vulnerable to changes in the intrauterine environment. Fetal HPA axis activity increases with gestation in most species and contributes to increased fetal levels of circulating glucocorticoids (Fowden et al. 1998). Even subtle changes in the intrauterine environment can disrupt the delicate balance of fetal HPA development and glucocorticoid production and can therefore alter long-term HPA activity and function. HPA hyperactivity has been demonstrated in animals after prenatal undernutrition (Lingas et al. 1999), prenatal stress (Takahashi and Kalin 1991) and maternal synthetic glucocorticoid administration (Uno et al. 1990, Sloboda et al. 2000). Programming of the fetal HPA axis during development appears to play a central role in the link between fetal growth and long-term disease in adulthood. Prenatal programming of HPA axis function may increase the risk of developing cardiovascular and metabolic diseases.",
author = "Sloboda, {Deborah M.} and Newnham, {John P.} and Moss, {Timothy J.M.} and Challis, {John R.G.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1017/CBO9780511544699.014",
language = "English",
isbn = "0521847435",
pages = "191--205",
booktitle = "Developmental Origins of Health and Disease",
publisher = "Cambridge University Press",
address = "United Kingdom",

}

Sloboda, DM, Newnham, JP, Moss, TJM & Challis, JRG 2006, The fetal hypothalamic–pituitary–adrenal axis: Relevance to developmental origins of health and disease. in Developmental Origins of Health and Disease. Cambridge University Press, pp. 191-205. https://doi.org/10.1017/CBO9780511544699.014

The fetal hypothalamic–pituitary–adrenal axis : Relevance to developmental origins of health and disease. / Sloboda, Deborah M.; Newnham, John P.; Moss, Timothy J.M.; Challis, John R.G.

Developmental Origins of Health and Disease. Cambridge University Press, 2006. p. 191-205.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - The fetal hypothalamic–pituitary–adrenal axis

T2 - Relevance to developmental origins of health and disease

AU - Sloboda, Deborah M.

AU - Newnham, John P.

AU - Moss, Timothy J.M.

AU - Challis, John R.G.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Introduction A clear relationship exists between intrauterine development and predisposition to postnatal disease. It is now understood that pre- and periconceptional nutritional status, glucocorticoid exposure and immediate postnatal development including catch-up growth may all contribute to these influences of early development on later-life disease. Barker and colleagues have described in detail the potential influence that an adverse intrauterine environment could play in the risk of developing particular diseases later in life (Barker 1994a, 1994b, 1995). It has been proposed that resetting of endocrine axes controlling growth and development could be one pathway for the developmental programming of later health and wellbeing. The fetal hypothalamic-pituitary-adrenal (HPA) axis in particular is highly vulnerable to changes in the intrauterine environment. Fetal HPA axis activity increases with gestation in most species and contributes to increased fetal levels of circulating glucocorticoids (Fowden et al. 1998). Even subtle changes in the intrauterine environment can disrupt the delicate balance of fetal HPA development and glucocorticoid production and can therefore alter long-term HPA activity and function. HPA hyperactivity has been demonstrated in animals after prenatal undernutrition (Lingas et al. 1999), prenatal stress (Takahashi and Kalin 1991) and maternal synthetic glucocorticoid administration (Uno et al. 1990, Sloboda et al. 2000). Programming of the fetal HPA axis during development appears to play a central role in the link between fetal growth and long-term disease in adulthood. Prenatal programming of HPA axis function may increase the risk of developing cardiovascular and metabolic diseases.

AB - Introduction A clear relationship exists between intrauterine development and predisposition to postnatal disease. It is now understood that pre- and periconceptional nutritional status, glucocorticoid exposure and immediate postnatal development including catch-up growth may all contribute to these influences of early development on later-life disease. Barker and colleagues have described in detail the potential influence that an adverse intrauterine environment could play in the risk of developing particular diseases later in life (Barker 1994a, 1994b, 1995). It has been proposed that resetting of endocrine axes controlling growth and development could be one pathway for the developmental programming of later health and wellbeing. The fetal hypothalamic-pituitary-adrenal (HPA) axis in particular is highly vulnerable to changes in the intrauterine environment. Fetal HPA axis activity increases with gestation in most species and contributes to increased fetal levels of circulating glucocorticoids (Fowden et al. 1998). Even subtle changes in the intrauterine environment can disrupt the delicate balance of fetal HPA development and glucocorticoid production and can therefore alter long-term HPA activity and function. HPA hyperactivity has been demonstrated in animals after prenatal undernutrition (Lingas et al. 1999), prenatal stress (Takahashi and Kalin 1991) and maternal synthetic glucocorticoid administration (Uno et al. 1990, Sloboda et al. 2000). Programming of the fetal HPA axis during development appears to play a central role in the link between fetal growth and long-term disease in adulthood. Prenatal programming of HPA axis function may increase the risk of developing cardiovascular and metabolic diseases.

UR - http://www.scopus.com/inward/record.url?scp=67650633583&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511544699.014

DO - 10.1017/CBO9780511544699.014

M3 - Chapter (Book)

SN - 0521847435

SN - 9780521847438

SP - 191

EP - 205

BT - Developmental Origins of Health and Disease

PB - Cambridge University Press

ER -

Sloboda DM, Newnham JP, Moss TJM, Challis JRG. The fetal hypothalamic–pituitary–adrenal axis: Relevance to developmental origins of health and disease. In Developmental Origins of Health and Disease. Cambridge University Press. 2006. p. 191-205 https://doi.org/10.1017/CBO9780511544699.014